Validation of chemokine receptor isoforms as drug targets for cancer therapy using Nanobody technology

Medicine & Life Sciences

1. Single-Domain Antibodies 100%
2. Chemokine Receptors 45%
3. Protein Isoforms 32%
4. Human Herpesvirus 4 30%
5. Technology 26%
6. Immunoglobulin Domains 19%
7. Pharmaceutical Preparations 16%
8. B-Cell Lymphoma 15%
9. G-Protein-Coupled Receptors 15%
10. Neoplasms 15%
11. Virus Diseases 11%
12. Epithelial Cells 10%
13. Viruses 10%
14. Carcinoma 10%
15. Therapeutics 8%
16. Antibodies 8%